Based on the aggregated intelligence of 125,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, Tenaris (NYSE:TS), a supplier of steel pipe products for the energy industry, has earned a coveted five-star ranking.

With that in mind, let's take a closer look at Tenaris' business, and see what CAPS investors are saying about the stock right now.

Tenaris facts

Headquarters (founded)

Luxembourg, Luxembourg (1909)

Market Cap

$13.58 billion


Oil and gas equipment

TTM Revenue

$11.52 billion


CEO Paolo Rocca (since 2002)

CFO Ricardo Soler (since 2007)

Return on Equity (average, last three years)


Dividend Yield



United States Steel (NYSE:X)

National Oilwell Varco (NYSE:NOV)

Ternium (NYSE:TX)

CAPS members bullish on TS also bullish on:

Freeport-McMoRan (NYSE:FCX)

CAPS members bearish on TS also bearish on:

Ryland Group (NYSE:RYL)

Vertex Pharmaceuticals (NASDAQ:VRTX)

Sources: Capital IQ (a division of Standard & Poor's) and Motley Fool CAPS. TTM = trailing 12 months.

Over on CAPS, 602 of the 617 members who have rated Tenaris -- or 98% -- believe the stock will outperform the S&P 500 going forward. These bulls include warsai553 and CAPS All-Star SapphireSeas.

Just yesterday, warsai553 tapped Tenaris as totally tubular: "Supplies tubing and certain services for energy companies. Clientele is diversified and distinguished, like Aramco. As demand for oil goes back up and exploration continues, there will be demand for this company's work in more places."

In a pitch from last month, SapphireSeas also was enthusiastic about the stock:

The price of crude might be testing new lows right now (January 2009), but that just won't last. No matter how deep this global recession, once things perk back up, China, India, and the West are going to take a long, thirsty sip, then a gulp, and then...bring on constrained supplies. Shazam! $200 oil in a jiff.

What do you think about Tenaris, or any other stock for that matter? Make your voice heard on Motley Fool CAPS today. CAPS is 100% free, so simply click here to get started.

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. National Oilwell Varco is a Motley Fool Stock Advisor pick. Vertex Pharmaceuticals is a Rule Breakers recommendation. The Fool's disclosure policy always gets a perfect score.